Objective. To identify perinatal outcomes in pregnant women with advanced maternal age (EMA) treated at the NationalMaternal Perinatal Institute. Materials and methods. Observational, descriptive and retrospective study of 321 maternaloutgoings occurred during the period from January 1 to June 30, 2016.

Objective. To identify perinatal outcomes in pregnant women with advanced maternal age (EMA) treated at the NationalMaternal Perinatal Institute. Materials and methods. Observational, descriptive and retrospective study of 321 maternaloutgoings occurred during the period from January 1 to June 30, 2016.

Introduction: Anemia is one of the main public health concerns in underdeveloped and developed countries; affects a quarter of the world's population, with considerable morbidity and mortality, especially in pregnant women (1)

The Peruvian Society of Obstetrics and Gynecology has contributed and will continue participating in the development of gynecology in Peru, including the subspecialty of climacteric and menopause, through the publication of scientific articles in The Peruvian Journal of Gynecology and Obstetrics. Various topics related to gynecological cancer, quality of life, cardiovascular health, sexuality, clinical aspects, osteoporosis and hormonal therapy in the climacteric and menopausal woman have been issued.

Postmenopausal women in the presence of abnormal uterine bleeding spontaneously and unexpectedly requires rigorous evaluation to determine the source of the bleeding. The most common cause of postmenopausal bleeding is endometrial atrophy and endometrial polyp; however, must be ruled endometrial cancer is the cause in about 10 percent of patients. The gold standard for evaluating the endometrium is transvaginal ultrasonography and endometrial biopsy, which are two key components that help reach an accurate diagnosis.

Postmenopausal women in the presence of abnormal uterine bleeding spontaneously and unexpectedly requires rigorous evaluation to determine the source of the bleeding. The most common cause of postmenopausal bleeding is endometrial atrophy and endometrial polyp; however, must be ruled endometrial cancer is the cause in about 10 percent of patients. The gold standard for evaluating the endometrium is transvaginal ultrasonography and endometrial biopsy, which are two key components that help reach an accurate diagnosis.

The genitourinary syndrome of menopause clinically is evident 4 to 5 years after menopause, and objective changes arepresent in 25-50% of all postmenopausal women. The most frequent symptoms are vaginal dryness ( 75%), dyspareunia(38%), and vaginal itching, vaginal discharge and pain (15%); and the diagnosis is based on clinical criteria. The principlestherapeutic are based on the restoration of urogenital physiology and relief of symptoms; including non-hormonal / lubricanttherapeutic options, systemic hormonal therapy, local estrogen therapy and other alternatives. The genitourinary syndromeof menopause is one of the most important determinants of sexual function and urogenital health, with a significant impact onthe quality of life related to female health.

The genitourinary syndrome of menopause clinically is evident 4 to 5 years after menopause, and objective changes arepresent in 25-50% of all postmenopausal women. The most frequent symptoms are vaginal dryness ( 75%), dyspareunia(38%), and vaginal itching, vaginal discharge and pain (15%); and the diagnosis is based on clinical criteria. The principlestherapeutic are based on the restoration of urogenital physiology and relief of symptoms; including non-hormonal / lubricanttherapeutic options, systemic hormonal therapy, local estrogen therapy and other alternatives. The genitourinary syndromeof menopause is one of the most important determinants of sexual function and urogenital health, with a significant impact onthe quality of life related to female health.

The evaluation of quality of life should focus mainly on the patient’s perception of her state of health, being an activeparticipant in this process. Instruments for measuring health-related quality of life (HRQL) can be classified into genericinstruments that measure multiple areas or domains and that are applicable to all individuals, regardless of the pathologythat affects them; And specific instruments, which are those that measure the functioning of the patient in one or severalareas and are characterized by paying particular attention to those symptoms or problems specific to a particular diseaseand those areas considered to be most affected, being only applicable to patients Specific. In daily clinical practice it is usefulto evaluate: improvement of clinical diagnosis, individualization and prioritization of treatments, improving the doctor-patientrelationship, and monitoring c...

Fetal growth restriction (RCF) is a clinical circumstance in which the fetus does not express its genetic potential for growth and as a final result a decrease in body weight occurs, which is below the 10th percentile for gestational age, in a selected growth curve. Among the etiological factors include: maternal, fetal and placental causes. It is classified as Precocious and late. The appropriate time for delivery is determined by gestational age and fetal condition.

The evaluation of quality of life should focus mainly on the patient’s perception of her state of health, being an activeparticipant in this process. Instruments for measuring health-related quality of life (HRQL) can be classified into genericinstruments that measure multiple areas or domains and that are applicable to all individuals, regardless of the pathologythat affects them; And specific instruments, which are those that measure the functioning of the patient in one or severalareas and are characterized by paying particular attention to those symptoms or problems specific to a particular diseaseand those areas considered to be most affected, being only applicable to patients Specific. In daily clinical practice it is usefulto evaluate: improvement of clinical diagnosis, individualization and prioritization of treatments, improving the doctor-patientrelationship, and monitoring c...

Fetal growth restriction (RCF) is a clinical circumstance in which the fetus does not express its genetic potential for growth and as a final result a decrease in body weight occurs, which is below the 10th percentile for gestational age, in a selected growth curve. Among the etiological factors include: maternal, fetal and placental causes. It is classified as Precocious and late. The appropriate time for delivery is determined by gestational age and fetal condition.